Skip to content

Blaastraining en PTNS bij overactieve blaas.

Bladder Training with or without PTNS (Posterior Tibial Nerve Stimulation) in the treatment of Overactive Bladder.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25864
Enrollment
60
Registered
2010-01-26
Start date
2009-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder. Urge incontinence/ aandrang incontinentie

Interventions

1. PTNS (Posterior tibial nerve stimulation)
2. Bladder training. Two arms: 1. Bladder training
2. Bladder training and PTNS.

Sponsors

NVA Nederlandse Vereniging voor Acupunctuur NVA (Nederlandse Vereniging voor Acupunctuur) Van Persijnstraat 17 3811 LS Amersfoort telnr: 0334654062
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients diagnosed with OAB syndrome will be included. Criteria for diagnosis are as follow: 1. Urgency and frequency: more than 8 voids per 24 hours and the sudden urge to void can hardly be suppressed; 2. Urge incontinence: urgency leading to urinary leakage occurring at least three times weekly; 3. Age > 18yrs.

Exclusion criteria

Exclusion criteria: 1. Symptoms existing for less than 6 months; 2. Pregnancy; 3. Active urinary tract or recurrent urinary tract infection; 4. Severe cardiopulmonary disease; 5. Diabetes with peripheral nerve involvement; 6. Neurological disorders; 7. Flowmetrie < 15mm/sec; 8. Had already treatment for overactive bladder.

Design outcomes

Primary

MeasureTime frame
ICIQ-ui-sf scores: Percentage of 70% improvement on the ICIQ-ui-sf scores. H0 hypothesis: There will be no difference in the ICIQ-sf scores of the two arms. Scores ranging from 0-21.

Secondary

MeasureTime frame
1. Incontinence episodes per week; 2. Frequency of micturition per 24h.

Contacts

Public ContactJohanna Biemans

Parkzichlaan 336-E

johanna@acupuncturist.nl+31 (0)6 29282976

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)